MA26423A1 - Procede pour la preparation de compose pharmaceutique et pour composition pharmaceutique le contenant, et procede pour sa production et son utilisation dans le traitement des maladies hyperproliferatives pour la peau - Google Patents
Procede pour la preparation de compose pharmaceutique et pour composition pharmaceutique le contenant, et procede pour sa production et son utilisation dans le traitement des maladies hyperproliferatives pour la peauInfo
- Publication number
- MA26423A1 MA26423A1 MA24528A MA24528A MA26423A1 MA 26423 A1 MA26423 A1 MA 26423A1 MA 24528 A MA24528 A MA 24528A MA 24528 A MA24528 A MA 24528A MA 26423 A1 MA26423 A1 MA 26423A1
- Authority
- MA
- Morocco
- Prior art keywords
- skin
- preparation
- treatment
- production
- composition containing
- Prior art date
Links
- 238000000034 method Methods 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000003463 hyperproliferative effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Liquid Crystal Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1380996P | 1996-03-21 | 1996-03-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA26423A1 true MA26423A1 (fr) | 2004-12-20 |
Family
ID=21761865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA24528A MA26423A1 (fr) | 1996-03-21 | 1997-03-21 | Procede pour la preparation de compose pharmaceutique et pour composition pharmaceutique le contenant, et procede pour sa production et son utilisation dans le traitement des maladies hyperproliferatives pour la peau |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0796843B1 (fr) |
| JP (1) | JP2801587B2 (fr) |
| KR (1) | KR100240541B1 (fr) |
| CN (1) | CN1110477C (fr) |
| AR (1) | AR006315A1 (fr) |
| AT (1) | ATE240941T1 (fr) |
| AU (1) | AU708679B2 (fr) |
| BR (1) | BR9701404A (fr) |
| CA (1) | CA2199893C (fr) |
| CO (1) | CO4820396A1 (fr) |
| CZ (1) | CZ85897A3 (fr) |
| DE (1) | DE69722064T2 (fr) |
| DK (1) | DK0796843T3 (fr) |
| ES (1) | ES2198512T3 (fr) |
| HR (1) | HRP970162A2 (fr) |
| HU (1) | HUP9700609A3 (fr) |
| ID (1) | ID16285A (fr) |
| IL (1) | IL120469A0 (fr) |
| MA (1) | MA26423A1 (fr) |
| MX (1) | MX9702139A (fr) |
| NO (1) | NO971217L (fr) |
| NZ (1) | NZ314424A (fr) |
| PE (1) | PE42998A1 (fr) |
| PL (1) | PL319070A1 (fr) |
| PT (1) | PT796843E (fr) |
| SG (1) | SG70589A1 (fr) |
| TR (1) | TR199700219A3 (fr) |
| TW (1) | TW444001B (fr) |
| YU (1) | YU10397A (fr) |
| ZA (1) | ZA972302B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9625271D0 (en) * | 1996-12-04 | 1997-01-22 | Leo Pharm Prod Ltd | Chemical compounds |
| US6331642B1 (en) * | 1999-07-12 | 2001-12-18 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
| KR101285720B1 (ko) * | 2012-03-02 | 2013-07-19 | 주식회사 유니크메디케어 | 여드름 개선용 조성물 |
| KR102493627B1 (ko) | 2015-11-26 | 2023-01-31 | 코웨이 주식회사 | 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA8923B (en) * | 1988-01-20 | 1989-09-27 | Hoffmann La Roche | 16-dehydro-vitamin d3-derivatives |
| DK0398217T3 (da) * | 1989-05-18 | 1994-02-14 | Hoffmann La Roche | Dehydrocholecalciferolderivater |
-
1997
- 1997-03-06 AU AU15135/97A patent/AU708679B2/en not_active Ceased
- 1997-03-11 SG SG1997000771A patent/SG70589A1/en unknown
- 1997-03-12 PE PE1997000190A patent/PE42998A1/es not_active Application Discontinuation
- 1997-03-13 TW TW086103109A patent/TW444001B/zh active
- 1997-03-13 CA CA002199893A patent/CA2199893C/fr not_active Expired - Fee Related
- 1997-03-14 DE DE69722064T patent/DE69722064T2/de not_active Expired - Fee Related
- 1997-03-14 AT AT97104387T patent/ATE240941T1/de not_active IP Right Cessation
- 1997-03-14 ES ES97104387T patent/ES2198512T3/es not_active Expired - Lifetime
- 1997-03-14 PT PT97104387T patent/PT796843E/pt unknown
- 1997-03-14 EP EP97104387A patent/EP0796843B1/fr not_active Expired - Lifetime
- 1997-03-14 DK DK97104387T patent/DK0796843T3/da active
- 1997-03-17 NO NO971217A patent/NO971217L/no not_active Application Discontinuation
- 1997-03-17 NZ NZ314424A patent/NZ314424A/en unknown
- 1997-03-17 ZA ZA9702302A patent/ZA972302B/xx unknown
- 1997-03-17 IL IL12046997A patent/IL120469A0/xx unknown
- 1997-03-18 JP JP9064030A patent/JP2801587B2/ja not_active Expired - Fee Related
- 1997-03-19 ID IDP970894A patent/ID16285A/id unknown
- 1997-03-19 AR ARP970101091A patent/AR006315A1/es not_active Application Discontinuation
- 1997-03-19 YU YU10397A patent/YU10397A/sh unknown
- 1997-03-19 HU HU9700609A patent/HUP9700609A3/hu unknown
- 1997-03-19 HR HR60/013,809A patent/HRP970162A2/xx not_active Application Discontinuation
- 1997-03-20 BR BR9701404A patent/BR9701404A/pt not_active IP Right Cessation
- 1997-03-20 MX MX9702139A patent/MX9702139A/es not_active IP Right Cessation
- 1997-03-20 PL PL97319070A patent/PL319070A1/xx unknown
- 1997-03-20 TR TR97/00219A patent/TR199700219A3/tr unknown
- 1997-03-20 CZ CZ97858A patent/CZ85897A3/cs unknown
- 1997-03-20 CO CO97015089A patent/CO4820396A1/es unknown
- 1997-03-20 KR KR1019970009478A patent/KR100240541B1/ko not_active IP Right Cessation
- 1997-03-20 CN CN97103358A patent/CN1110477C/zh not_active Expired - Fee Related
- 1997-03-21 MA MA24528A patent/MA26423A1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69312631D1 (de) | Material für die behandlung von tierexkrementen und verfahrung zu dessen herstellung | |
| ATE232543T1 (de) | 11beta-halogen-7alpha-substituierte-estratriene verfahren zur herstellung pharmazeutischer präparate, die diese 11beta-halogen-7alpha- substituierte-estratriene enthalten, sowie deren verwendung zur herstellung von arzneimitteln | |
| FR2526443B1 (fr) | Activateur de plasminogene de tissu humain, son procede de production et composition pharmaceutique le contenant | |
| DE69638198D1 (de) | Verfahren und Reagenz zur Behandlung von Krankheiten die von der Konzentration des Rezeptors für den Wachstumsfaktor der vaskulären Endothelzellen verursacht werden | |
| FR2523152B1 (fr) | Produit proteinique d'expression et de traitement par un micro-organisme et son procede d'obtention | |
| FR2737118B1 (fr) | Composition dermatologique ou pharmaceutique, procede de preparation et utilisation | |
| HUP0301101A3 (en) | Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases | |
| MA26658A1 (fr) | Derivés de valérohydrazine, procédé pour les préparer, médicament pour le traitement des maladies inflammatoires et auto-immunes les contenant, et leur utilisation pour préparer un tel médicament | |
| DE69506431D1 (de) | Stärkeprodukte als tablettierhilfstoff, verfahren zu deren herstellung und verfahren zur herstellung von tabletten | |
| FR2598433B1 (fr) | Procede de production d'interleukine-2 humaine, interleukine-2 ainsi obtenue, son utilisation a titre de medicament et composition pharmaceutique la contenant | |
| FR2599253B1 (fr) | Produit liquide pour le traitement esthetique de la peau et son procede de fabrication. | |
| FR2510889B1 (fr) | Medicament contenant certains phosphates ribofurannosyl-3',5'-cycliques substitues en 6, 8 pour le traitement de maladies proliferatives de la peau | |
| ATA900589A (de) | Stereospezifisches verfahren fuer die herstellung von enantiomeren des 3-substituierten furo (3,4-c) pyridins, so erhaltene enantiomere oder mischungen davon sowie diese enthaltene therapeutische mittel | |
| FR2563104B1 (fr) | Composition de traitement de la peau contenant des particules granulaires | |
| MA26423A1 (fr) | Procede pour la preparation de compose pharmaceutique et pour composition pharmaceutique le contenant, et procede pour sa production et son utilisation dans le traitement des maladies hyperproliferatives pour la peau | |
| FR2717080B1 (fr) | Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales. | |
| FR2600891B1 (fr) | Produit pharmaceutique pour la stimulation de l'apprentissage et l'amelioration de la memoire contenant comme principe actif, le chlorhydrate de 9-amino-2,3, 5,6,7,8,-hexahydro-14-cyclopenta(b)quinoline monohydrate | |
| EE9600023A (et) | Fenüültsükloheksüülkarboksüülhappeamiidid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod | |
| MA26683A1 (fr) | Derives de piperidine, procede pour leur preparation, medicaments les contenant et leur utilisation dans le traitement de troubles neurologiques et physiologiques | |
| FR2614203B1 (fr) | Composition pharmaceutique pour le traitement des maladies de la peau et son procede de preparation. | |
| DE68903059D1 (de) | Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten. | |
| FR2753628B1 (fr) | Produit destine a prevenir et a soigner les maladies de la peau, procede d'elaboration et utilisation dudit produit | |
| DE69512977D1 (de) | Material für die Behandlung von Tierexkrementen und Verfahren zu dessen Herstellung | |
| PT84697A (fr) | Procede pour la preparation de compositions pour le traitement de la calvitie et des alopecies contenant phenytoine et diazoxyde | |
| FR2726267B1 (fr) | Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer |